Mineralys Therapeutics, Inc. Profile Avatar - Palmy Investing

Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administ…

Biotechnology
US, Radnor [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Mineralys Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Mineralys Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Mineralys Therapeutics, Inc..

End of MLYS's Analysis
CIK: 1933414 CUSIP: 603170101 ISIN: US6031701013 LEI: - UEI: -
Secondary Listings
MLYS has no secondary listings inside our databases.